Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Androgens And The Ageing Male.

A. Juul, N. Skakkebaek
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Hypogonadal men share a variety of signs and symptoms such as decreased muscle mass, osteopoenia, increased fat mass, fatigue, decreased libido and cognitive dysfunctions. Controlled trials have demonstrated favourable effects of androgen substitution therapy on these signs and symptoms in men with severe primary or secondary hypogonadism. Thus, androgen substitution therapy is warranted in men with true hypogonadism at all ages. Symptoms experienced by otherwise healthy ageing males are non-specific and vague, although some may be similar to symptoms of hypogonadism. Therefore, the term 'andropause' has been suggested. However, testosterone levels show no or only modest variation with age in men; with large prospective studies suggesting a maximal decline of total testosterone of 1.6% per year. Thus, in contrast to the sudden arrest of gonadal activity in females around menopause, men do not have an andropause. As large placebo-controlled studies of androgen treatment in elderly males are lacking, proper risk assessment of adverse effects such as prostate cancer following testosterone treatment in elderly males is completely lacking. In the future, testosterone therapy may prove beneficial in some elderly males with low-normal testosterone levels. However, at this point in time, widespread use of testosterone in an elderly male population outside controlled clinical trials seems inappropriate.
This paper references
Cardiovascular risk factors in men : the role of gonadal steroids and sex hormonebinding globulin
J. Gyllenborg (2001)
10.1177/000456328602300202
Testosterone Assays: Guidelines for the Provision of a Clinical Biochemistry Service
A. A. Ismail (1986)
10.1016/0039-128X(94)00055-H
A method for measurement of free testosterone in premenopausal women involving equilibrium dialysis, chromatography, and radioimmunoassay
A. Törmä (1995)
10.1210/JC.2003-030611
Endogenous sex hormones and cardiovascular disease in men.
M. Muller (2003)
10.1016/S1440-2440(99)80007-3
Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study.
A. Giorgi (1999)
The DSL analog free testosterone assay: serum levels are not related to sex hormone-binding globulin in normative data throughout childhood and adolescence.
J. Kratzsch (2001)
10.1097/00132586-198006000-00002
Sleep Apnea, Hypopnea and Oxygen Desaturation in Normal Subjects: A Strong Male Predominance
A. Block (1980)
10.1042/CS1000661
Effect of cigarette smoking on levels of bioavailable testosterone in healthy men.
K. English (2001)
10.1016/0021-9150(95)05673-4
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men.
S. Zgliczyński (1996)
10.1002/(SICI)1097-4679(199706)53:4<375::AID-JCLP11>3.0.CO;2-D
Serum testosterone in adult sex offenders: a comparison between Caucasians and North American Indians.
L. Studer (1997)
Validation of a screening questionnaire for androgen de®ciency in aging
J. E. Morley (2000)
10.1210/JCEM.83.4.4718
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women.
I. Sinha-Hikim (1998)
10.1055/S-2007-978950
Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
D. Tripathy (1998)
10.1097/00006842-199905000-00007
Testosterone, gonadotropin, and cortisol secretion in male patients with major depression.
U. Schweiger (1999)
10.1210/JCEM.84.8.5885
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age.
P. Snyder (1999)
10.1111/j.1365-2265.1985.tb00161.x
TESTOSTERONE REPLACEMENT IN HYPOGONADAL MEN: EFFECTS ON OBSTRUCTIVE SLEEP APNOEA, RESPIRATORY DRIVES, AND SLEEP
A. Matsumoto (1985)
10.1161/01.ATV.13.4.517
Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study.
J. Yarnell (1993)
10.1161/01.CIR.78.3.539
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.
E. Barrett-connor (1988)
10.1210/JCEM-57-3-557
The nature of androgen action on male sexuality: a combined laboratory-self-report study on hypogonadal men.
M. Kwan (1983)
10.1016/0378-5122(89)90003-0
The questionable physiologic and epidemiologic basis for a male climacteric syndrome: preliminary results from the Massachusetts Male Aging Study.
J. Mckinlay (1989)
10.1161/01.CIR.99.13.1666
Acute anti-ischemic effect of testosterone in men with coronary artery disease.
G. Rosano (1999)
10.1093/OXFORDJOURNALS.AJE.A009326
Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants.
J. Zmuda (1997)
10.1359/jbmr.1997.12.11.1833
Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study
G. Greendale (1997)
10.1016/S1062-1458(00)00172-0
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
D. Herrington (2000)
10.1093/GERONA/56.5.M266
Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
A. Kenny (2001)
10.1161/01.ATV.11.3.489
Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men.
K. Khaw (1991)
10.1210/JCEM.84.5.5708
Diurnal rhythm in serum levels of inhibin B in normal men: relation to testicular steroids and gonadotropins.
Elisabeth Barfod Carlsen (1999)
10.1023/A:1016663523579
Bioavailable Testosterone as a Correlate of Cognition, Psychological Status, Quality of Life, and Sexual Function in Aging Males: Implications for Testosterone Replacement Therapy
P. Perry (2001)
10.4158/EP.6.2.132
Testosterone treatment in hypogonadal men: prostate-specific antigen level and risk of prostate cancer.
A. Guay (2000)
Age differences in serum androgen levels in normal adult males.
F. E. Purifoy (1981)
10.7326/0003-4819-132-9-200005020-00002
Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study
D. Grady (2000)
10.1055/S-2007-971955
Muscle strength and hormonal levels in adolescents: gender related differences.
E. Ramos (1998)
10.1111/j.1600-0447.1988.tb06313.x
Hypothalamic‐pituitary‐gonadal axis in major depressive disorders
F. Undén (1988)
Bene®cial effects of testosterone undecanoate on the lipoprotein pro®les in healthy elderly men. A placebo controlled study
B. S. Uyanik (1997)
10.1053/META.2001.24916
Cardiovascular risk factors in men: The role of gonadal steroids and sex hormone-binding globulin.
J. Gyllenborg (2001)
10.1210/JCEM.79.2.8045977
Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men.
C. Bagatell (1994)
10.1007/s001980070068
Prevalence of Low Serum Estradiol Levels in Male Osteoporosis
C. G. Carlsen (2000)
10.1056/NEJM198804143181517
Male hypogonadism and bone fracture.
C. Swartz (1988)
10.1210/JCEM.85.9.6825
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
Annewieke W. van den Beld (2000)
10.1097/00008469-200106000-00012
Testosterone and oestradiol in relation to tobacco smoking, body mass index, energy consumption and nutrient intake among adult men
R. Tamimi (2001)
10.1210/JCEM.86.8.7773
Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.
T. Münzer (2001)
10.1097/00006842-197805000-00007
Serum testosterone and aggressiveness in hockey players.
T. J. Scaramella (1978)
10.1093/AJCP/81.6.754
Serum testosterone measurements.
W. J. Boyle (1984)
10.1210/JCEM-65-6-1118
The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
J. S. Tenover (1987)
10.4088/JCP.V62N0602
Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
S. Seidman (2001)
Risks and bene ® ts of estrogen plus progestin in healthy post menopausal women
J. W. Yarnell (2002)
10.1002/(SICI)1097-0045(19990501)39:2<130::AID-PROS8>3.0.CO;2
CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.
E. Giovannucci (1999)
10.1176/AJP.134.6.692
Testosterone and components of aggressive and sexual behavior in man.
P. Monti (1977)
10.1001/JAMA.279.9.663
Insurance coverage, physician recommendations, and access to emerging treatments: growth hormone therapy for childhood short stature.
B. Finkelstein (1998)
10.1536/IHJ.38.73
Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study.
B. Uyanık (1997)
10.7326/0003-4819-133-12-200012190-00008
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
F. Grodstein (2000)
10.1111/j.1365-2265.1981.tb00364.x
ANDROGEN REPLACEMENT WITH ORAL TESTOSTERONE UNDECANOATE IN HYPOGONADAL MEN: A DOUBLE BLIND CONTROLLED STUDY
N. Skakkebaek (1981)
10.1016/0039-128X(88)90178-X
Effect of tracer binding to serum proteins on the reliability of a direct free testosterone assay
G. Giraudi (1988)
10.1515/CCLM.1984.22.5.371
[The effect of storage and temperature on the analysis of steroids in plasma and blood].
H. Kley (1984)
10.1053/META.2000.7710
Testosterone and leptin in older African-American men: relationship to age, strength, function, and season.
H. Perry (2000)
10.1210/JCEM.74.3.1371291
Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
J. Mcconnell (1992)
10.1210/JCEM.87.2.8201
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.
H. Feldman (2002)
10.1001/JAMA.1989.03420080085036
Contrasting effects of testosterone and stanozolol on serum lipoprotein levels.
P. Thompson (1989)
10.1046/J.1365-2605.1999.00196.X
Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone.
E. Jannini (1999)
10.1016/S0047-6374(98)00130-4
Predictors of skeletal muscle mass in elderly men and women
R. Baumgartner (1999)
10.1210/JCEM.86.6.7643
An extraordinarily inaccurate assay for free testosterone is still with us.
W. Rosner (2001)
10.1016/S0009-9120(97)00143-4
Establishing reference intervals for DPC's free testosterone radioimmunoassay.
D. Ooi (1998)
10.1359/jbmr.2000.15.11.2222
A TA Repeat Polymorphism in the Estrogen Receptor Gene Is Associated with Osteoporotic Fractures but Polymorphisms in the First Exon and Intron Are Not
B. Langdahl (2000)
10.1056/NEJM199607043350101
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.
S. Halender (1996)
10.1210/JCEM.85.1.6327
Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study.
E. Barrett-connor (2000)
10.1093/JNCI/88.16.1118
Prospective study of sex hormone levels and risk of prostate cancer.
P. Gann (1996)
10.1056/NEJM198711053171901
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
D. Kiel (1987)
10.7326/0003-4819-117-10-807
Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus.
E. Barrett-connor (1992)
Anabolic androgenic steroids and a stroke in an athlete: case report.
M. Frankle (1988)
10.1136/BMJ.2.6046.1255-A
The Framingham study.
W. Kannel (1976)
10.1002/(SICI)1097-0045(19990501)39:2<130::AID-PROS8>3.0.CO;2-#
CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians
E. Giovannucci (1999)
10.1016/S0021-9150(96)06041-8
Behavioral correlates of plasma sex hormones and their relationships with plasma lipids and lipoproteins in Japanese men.
K. Handa (1997)
10.1210/JCEM.82.12.4456
Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men.
T. Jensen (1997)
10.1002/J.1939-4640.1990.TB00178.X
Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men.
C. Contoreggi (1990)
10.1210/JCEM.82.11.4387
Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis.
R. Hajjar (1997)
10.1046/j.1365-2265.1997.1660984.x
The safety profile of GH replacement therapy in adults
J. Chipman (1997)
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
(1997)
10.1210/JCEM.86.10.7889
The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity.
M. Zitzmann (2001)
10.1016/0378-5122(92)90056-A
Middle-aged Danish men's ideas of a male climacteric--and of the female climacteric.
K. Solstad (1992)
10.1007/BF01552912
Frequency of sexual problems and sexual dysfunction in middle-aged Danish men
K. Solstad (1993)
10.1053/META.2000.8625
Validation of a screening questionnaire for androgen deficiency in aging males.
J. Morley (2000)
10.1001/ARCHPSYC.57.2.133
Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.
H. Pope (2000)
10.1016/0047-6374(89)90099-7
Effects of progressive resistance training on growth hormone and testosterone levels in young and elderly subjects
B. Craig (1989)
10.1210/JCEM-56-6-1278
Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.
W. Bremner (1983)
10.1159/000030515
Relation of Sexual Dysfunction to Hormone Levels, Diseases and Drugs Used in Andrological Patients
W. Krause (2000)
10.1210/JCEM.84.10.6079
A critical evaluation of simple methods for the estimation of free testosterone in serum.
A. Vermeulen (1999)
10.1016/0002-9149(88)91390-2
Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids.
R. A. McNutt (1988)
10.1210/JCEM-34-4-730
Testosterone secretion and metabolism in male senescence.
A. Vermeulen (1972)
10.1530/ACTA.0.0800171
Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol.
K. M. Pirke (1975)
10.7326/0003-4819-106-3-
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
J. Finkelstein (1987)
Postmenopausal hormone therapy increases risk for venous thromboembolic disease
D. Grady (2000)
10.1093/CLINCHEM/28.5.1237
Free-testosterone determination by ultrafiltration, and comparison with dialysis.
P. J. Green (1982)
A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
P. Kantoff (1997)
10.1001/JAMA.280.7.605
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
S. Hulley (1998)
10.1093/clinchem/44.10.2178
The analog free testosterone assay: are the results in men clinically useful?
S. Winters (1998)
10.1016/S0009-9120(89)80097-9
Determination of free testosterone fraction of human serum by gel bead dialysis.
R. Lavoie (1989)
10.1046/j.1365-2710.2000.00309.x
The effect of testosterone on health‐related quality of life in elderly males – a pilot study
P. Reddy (2000)
10.1016/S0026-0495(97)90057-3
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.
J. Morley (1997)
10.1210/JCEM.84.6.5741
Effect of testosterone treatment on bone mineral density in men over 65 years of age.
P. Snyder (1999)
10.1002/J.1939-4640.1994.TB00433.X
A ten-year safety study of the oral androgen testosterone undecanoate.
L. Gooren (1994)
The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
C. Haiman (2001)
10.1210/JCEM.86.2.7219
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.
S. Harman (2001)
10.1054/GHIR.2001.0195
The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
S. Fisker (2001)
10.1210/JCEM.85.8.6747
Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
C. Wang (2000)
10.1111/j.1365-2265.1976.tb01964.x
CHANGES IN THE PITUITARY‐TESTICULAR SYSTEM WITH AGE
H. Baker (1976)
10.1056/NEJM200008243430801
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
D. Herrington (2000)
10.1056/nejm199607043350101
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.
S. Bhasin (1996)
10.1016/0895-4356(91)90028-8
An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis.
A. Gray (1991)
10.1002/(SICI)1097-4679(199607)52:4<475::AID-JCLP14>3.0.CO;2-D
Serum testosterone in violent and nonviolent young offenders.
J. H. Brooks (1996)
10.1210/JCEM.75.4.1400877
Effects of testosterone supplementation in the aging male.
J. S. Tenover (1992)
10.1177/174182679700400508
Testosterone, Sex Hormone-Binding Globulin, Lipoproteins, and Vascular Disease Risk
R. Dickerman (1997)
10.1177/14746514020020040801
Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study
J. Levy (2002)
10.1172/JCI10942
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.
A. Falahati-Nini (2000)
10.1056/NEJM199410203311604
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man.
E. Smith (1994)
10.1210/JCEM-57-1-71
Hormonal changes and sexual function in aging men.
J. M. Davidson (1983)
10.1161/01.CIR.102.16.1906
Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With Chronic Stable Angina: A Randomized, Double-Blind, Placebo-Controlled Study
K. English (2000)
10.1210/JCEM.82.6.3988
Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.
R. Sih (1997)
10.1016/S0006-3223(01)01148-9
Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men
S. Seidman (2001)
10.1210/JCEM.85.3.6437
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
C. Wang (2000)
10.1210/JCEM.86.10.7942
Report of National Institute on Aging Advisory Panel on Testosterone Replacement in Men.
Advisory Panel on Testosterone Replacement in Men (2001)
10.1152/AJPENDO.00362.2001
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.
A. Ferrando (2002)
J. Am. Med. Assoc
10.1210/JCEM.85.8.6731
Effects of testosterone replacement in hypogonadal men.
P. Snyder (2000)
10.1093/HUMREP/15.2.366
High frequency of sub-optimal semen quality in an unselected population of young men.
A. Andersen (2000)
10.1210/JCEM.86.8.7736
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.
S. Khosla (2001)
10.1210/JCEM.81.8.8768865
A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women.
D. Goodman-gruen (1996)
10.1097/00006254-198807000-00018
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
D. Kiel (1987)
Cardiovascular risk factors in men: the role of gonadal steroids and sex
J. Gyllenborg (2001)



This paper is referenced by
Spatial-temporal analysis of endocrine disruptor pollution, neighbourhood stress, maternal age and related factors as potential determinants of birth sex ratio in Scotland
Ewan W. McDonald (2013)
10.1080/13685530500048872
Testosterone supplementation in the aging male: Which questions have been answered?
W. Krause (2005)
Intérêt du dosage de testostérone biodisponible pour le diagnostic du déficit androgénique chez l'homme âgé
H. Lejeune (2003)
10.1371/journal.pone.0109346
A Validated Age-Related Normative Model for Male Total Testosterone Shows Increasing Variance but No Decline after Age 40 Years
T. Kelsey (2014)
Androgen therapy: testing before prescribing and monitoring during therapy.
A. Katz (2007)
Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer.
A. Sinha (2016)
10.1371/journal.pone.0049173
Subcellular Localization of p44/WDR77 Determines Proliferation and Differentiation of Prostate Epithelial Cells
S. Gao (2012)
Testosterone deficiency in men. Diagnosis and management.
C. Allan (2003)
10.4061/2011/251517
A Novel Mouse Model of Alzheimer's Disease with Chronic Estrogen Deficiency Leads to Glial Cell Activation and Hypertrophy
A. Prat (2011)
10.3389/fnagi.2015.00140
The quasi-parallel lives of satellite cells and atrophying muscle
S. Biressi (2015)
Carcinoma da próstata e envelhecimento: aspectos preocupantes
F. Pina (2006)
Pubertal hormones alter circadian timekeeping: Evidence from two rodent models, Rattus norvegicus and Octodon degus.
M. Hagenauer (2010)
10.1021/acs.jproteome.9b00451
Spatiotemporal proteomics reveals the molecular consequences of hormone treatment in a mouse model of lower urinary tract dysfunction.
S. Thomas (2020)
10.1089/rej.2011.1249
Hormonal therapy of intrinsic aging.
C. Zouboulis (2012)
10.1138/20050152
Clinical and basic research papers - February 2005 selections
E. Seeman (2005)
10.1080/13685530701433121
Analysis of the discriminant ability of shorter versions of the French ADAM questionnaire
A. Tancredi (2007)
10.7326/0003-4819-151-9-200911030-00150
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Alexander Tsertsvadze (2009)
10.1007/978-3-540-76821-0_4
Endokrinologische Aspekte der Hautalterung
K. Fritz (2008)
10.1097/01.PRS.0000125283.18798.DA
Anti-aging medicine: hormone replacement therapy in men.
S. Kaweski (2004)
10.2217/AHE.09.6
Therapeutic potential of testosterone gels
B. Lunenfeld (2009)
10.1007/s00415-011-5914-3
Hypogonadism in DM1 and its relationship to erectile dysfunction
G. Antonini (2011)
10.1111/J.1743-6109.2007.00689.X
Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients.
T. Amano (2008)
10.4236/JBBS.2013.37054
Sex-Role Orientation in Men Is Related to Salivary Testosterone Levels
Miriam J. Law Smith (2013)
10.1177/1557988309335154
Awareness and Knowledge of Andropause Among Chinese Males in Hong Kong
Yuk Yee Yan (2010)
10.1080/13685538.2020.1764927
Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents.
D. A. M. Hermoso (2020)
10.1038/sj.embor.7400269
Hormone therapy for the ageing
A. Rinaldi (2004)
10.1002/cncr.31153
Androgen‐deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?
D. McHugh (2018)
10.15064/JJPM.44.6_415
男性更年期障害におけるHAD尺度と国際勃起スコア5(IIEF 5)の検討(男性更年期の心身医学)(第44回日本心身医学会総会)
馬場 克幸 (2004)
10.1519/JSC.0b013e3181d4d409
The Association between Athleticism, Prenatal Testosterone, and Finger Length
Dani M. Moffit (2011)
Semen Parameters Associated With Male Infertility in a Sub-Saharan Black Population : The Effect of Age and Body Mass Index
A. Ajayi (2018)
10.1053/j.seminoncol.2008.08.002
Cognitive effects of hormonal therapy in older adults.
N. Mitsiades (2008)
10.5807/KJOHN.2012.21.3.239
Depression and Health Promoting Behavior Depending on the Climacteric Symptoms of Middle-aged Male Workers
허명륜 (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar